Medical Cannabis Archives - Page 22 of 104

Neurological Disorders in Medical Use of Cannabis: An Update

Canna Clinical TrialsBy WW 19th June 2020 Leave a comment

Medical cannabis is increasingly used as a treatment or adjunct treatment with different levels of efficacy in several neurological disorders or related symptoms (such as multiple sclerosis, autism, Parkinson and Alzheimer disease, Tourette’s syndrome, Huntington’s disease, neuropathic pain, epilepsy, headache), as well as in other medical conditions (e.g. nausea and vomiting, glaucoma, appetite stimulation, cancer, inflammatory conditions, asthma).

Cannabinoid Signaling in Health and Disease

Canna Clinical TrialsBy WW 18th June 2020 Leave a comment

Cannabis sativa has long been used for medicinal purposes. To improve safety and efficacy, compounds from C. sativa were purified or synthesized and named under an umbrella group as cannabinoids. Currently, several cannabinoids may be prescribed in Canada for a variety of indications such as nausea and pain.

Medical Use of Cannabis: Italian and European Legislation

Canna Clinical TrialsBy WW 17th June 2020 Leave a comment

This review illustrates some brief considerations of the medical use of cannabis recently issued in Italy. History and uses of cannabis throughout centuries and different countries are illustrated together with a description of botany and active phytocannabinoids.

Validation of Clinical Vignettes to Explore Medical Cannabis Practices

Canna Clinical TrialsBy WW 16th June 2020 1 Comment

The policies and practices related to medical cannabis are currently in flux. These changes have been associated with many controversies, and there is a lack of consensus within the medical community regarding medical cannabis practices.

A Comprehensive Review of Cannabis in Patients With Cancer: Availability in the USA, General Efficacy, and Safety

Canna Clinical TrialsBy WW 14th June 2020 Leave a comment

As the legalization of medical cannabis continues across the USA, oncology care providers will be increasingly asked to provide recommendations regarding its use in the cancer setting. In this article, we review recent literature that analyzes cannabis use specifically in patients with cancer and provide an accessible guide for clinicians, researchers, and patients.

Opportunities for Cannabis in Supportive Care in Cancer

Canna Clinical TrialsBy WW 11th June 2020 Leave a comment

Cannabis has the potential to modulate some of the most common and debilitating symptoms of cancer and its treatments, including nausea and vomiting, loss of appetite, and pain. However, the dearth of scientific evidence for the effectiveness of cannabis in treating these symptoms in patients with cancer poses a challenge to clinicians in discussing this option with their patients.

Cannabis Use in Young Adult Cancer Patients

Canna Clinical TrialsBy WW 10th June 2020 Leave a comment

Cannabis species have been used as medicine for thousands of years; only since the 1940s has the plant not been widely available for medical use. However, an increasing number of jurisdictions are making it possible for patients to obtain the botanical for medicinal use.

Cannabis Use in Young Adult Cancer Patients

Canna Clinical TrialsBy WW 9th June 2020 Leave a comment

The use of cannabis by young adult (YA) cancer patients is likely to increase as medical cannabis becomes more available. Clinically relevant data on cannabis use are needed to establish benchmarks for use, to identify patients who are more likely to use cannabis, and to assess outcomes associated with use.

Cannabis Use in Young Adult Cancer Patients

Canna Clinical TrialsBy WW 5th June 2020 Leave a comment

Rates of Cannabis Use in Patients With Cancer

Canna Clinical TrialsBy WW 4th June 2020 Leave a comment

A comprehensive assessment of cannabis use by patients with cancer has not previously been reported. In this study, we aimed to characterize patient perspectives about cannabis and its use.

Tag Archives: Medical Cannabis